eli lilly tirzepatide shortage Lilly's Weight-Loss Drug Zepbound Is Officially Over: FDA Mounjaro, Zepbound Shortage Ends. What

That year one in eight people were thought to be living with obesity around the world (WHO 2024)

In a 2022 study, scientists concluded that MOTS-c plays an essential physiological role in mitochondrial function and appears to be a promising therapy for [ME/CFS] associated fatigue. This means MOTS-c could potentially help restore cellular energy production in conditions where it is deficient, thereby improving stamina and reducing chronic fatigue

The Nudge prescribes this medication off label from its intended use

You may come in weekly, monthly, or every 3 months for follow-up appointments

Sleep quality improvement Sleep disruption is a frequently reported side effect during GLP-1 therapy